Fred Vasseur Continues With Scuderia Ferrari hp
Maranello (Italy), July 31, 2025 – Ferrari N.V. ('Ferrari') (NYSE/EXM: RACE) announced today that Ferrari S.p.A. has extended, with a multiple-year contract, its agreement with Fred Vasseur, who will continue as Team Principal of Scuderia Ferrari HP for the coming Formula 1 seasons.
Fred joined the Scuderia at the beginning of 2023, bringing with him extensive motorsport experience and a proven ability to develop talent and build competitive teams across all levels of racing. Since then, he has laid a solid foundation with the ambition of returning Ferrari to the top of Formula 1.
Renewing Fred's contract reflects our determination to build on the foundations laid so far. His ability to lead under pressure, embrace innovation, and pursue performance aligns fully with Ferrari's values and long-term ambitions.
Under Fred's leadership, Scuderia Ferrari HP is united, focused, and committed to continuous improvement. The trust placed in him reflects the team's confidence in its strategic direction and reinforces a shared determination to deliver the results that Ferrari's fans, drivers, and team members expect and deserve.
Benedetto Vigna, CEO Ferrari:
'Today we want to recognize what has been built and commit to what still needs to be achieved. It reflects our trust in Fred's leadership — a trust rooted in shared ambition, mutual expectations and clear responsibility. We move forward with determination and focus, united in our pursuit of the level of performance Ferrari has to aim for.'
Fred Vasseur, Team Principal Scuderia Ferrari HP:
'I'm grateful for the trust Ferrari continues to place in me. This renewal is not just a confirmation — it's a challenge to keep progressing, to stay focused, and to deliver. Over the past 30 months, we've laid strong foundations, and now we must build on them with consistency and determination. We know what's expected, and we're all fully committed to meeting those expectations and taking the next step forward together.'
Attachment
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
Key Points Hims & Hers Health is unlocking new sources of growth potential, and its balance sheet is flourishing. Doximity is a prime platform for advertisers, and the profits are pouring in. 10 stocks we like better than Hims & Hers Health › It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very personal process. You need to consider the type of stocks you want to buy, the industries and sectors you gravitate toward, the amount of capital you have to invest, and your own personal risk tolerance. If you have cash to invest in the stock market right now, and you're looking for growth stocks that could make smart additions to the basket of businesses you own, there are names to be found across a range of industries, including healthcare. Here are two healthcare stocks that have at least doubled over the past 12 months but still look poised to deliver favorable returns for shareholders in the next three to five years. 1. Hims & Hers Health Hims & Hers Health (NYSE: HIMS) has witnessed a stock run-up of more than 200% over the trailing-12-month period. In contrast, the S&P 500 is up only about 18% in that same time frame. This boom in the company's share price has occurred for a few reasons. Investors were particularly excited about the company's ability to offer affordable, compounded GLP-1 drugs for weight loss amid shortages of branded versions, and that fueled significant revenue growth and share-price appreciation. However, Hims & Hers can no longer mass-produce compounded drugs like semaglutide because the U.S. Food and Drug Administration declared the shortage resolved. While the company may still offer personalized doses where clinically applicable, its primary weight loss offerings are shifting to oral medications and liraglutide. In fact, Novo Nordisk, the maker of Wegovy (semaglutide for weight) and Ozempic (semaglutide for diabetes), ended its partnership with Hims & Hers, citing concerns over the latter company's promotion and sales of compounded semaglutide. While the company's offerings may evolve in the coming months and years, it has other sources of growth to lean on besides the weight loss segment. Hims & Hers' areas of focus include sexual health, hair loss, dermatology, mental health, and primary care. The platform also provides access to both over-the-counter and prescription treatments via online consultations with licensed healthcare professionals, and most of its revenue still comes from recurring subscriptions paid by healthcare consumers. The recent acquisition of Zava, a European digital health platform, seems to have boosted investor confidence in the future of the business outside of its ambitions in the weight loss industry. The addition of Zava to Hims & Hers' ecosystem will expand its reach into the U.K., Ireland, France, and Germany. Hims & Hers also plans to launch its platform in Canada in 2026. Revenue grew by 110% year over year in the first quarter, and the company is building upon an improving track record of profitability. Hims & Hers also delivered free cash flow of about $50 million in Q1. This business has a lot of potential. 2. Doximity Doximity (NYSE: DOCS) has seen shares pop by a bit more than 100% since this time one year ago. Doximity is known as the largest digital platform for U.S. medical professionals. It serves as a professional and social network for healthcare professionals including doctors, nurse practitioners, and physician assistants, and offers a wide variety of tools for communication, news, and career management. Doximity provides a curated newsfeed with the latest medical news and research relevant to different specialties, and also offers tools for job searches, salary comparisons, and reputation management. The platform even provides telehealth solutions, enabling virtual patient visits and consultations. The platform is free for healthcare professionals to use. This free access includes Doximity Dialer, a feature that allows secure communication with patients using a customized calling tool. The platform also offers free digital fax lines and access to Doximity Scribe, an AI-powered note-taking tool for verified clinicians. So, how does Doximity make money? From advertising and selling information. Doximity's platform is a prime digital marketing and advertising tool for pharmaceutical manufacturers and healthcare systems (like hospitals). These entities pay Doximity to advertise and promote their products and services to targeted medical professionals. Health systems and medical recruiting firms also pay Doximity to access its database of medical professionals for recruitment and hiring purposes. In Doximity's fiscal 2025, which ended March 31, revenue increased 20% from the prior fiscal year to $570.4 million. The company reported net income of $223.2 million, up 51% year over year, with free cash flow spiking 50% to $266.7 million. This healthcare stock is really an advertising business at its core, and a profitable one at that. These factors could induce some investors to take another long look at this top stock and I think it has room to run. Do the experts think Hims & Hers Health is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Hims & Hers Health make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,019% vs. just 178% for the S&P — that is beating the market by 841.12%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Rachel Warren has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Doximity and Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run was originally published by The Motley Fool 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Newsweek
3 hours ago
- Newsweek
Lewis Hamilton Hints at Off-Track Issues After Painful Hungarian GP
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Ferrari driver Lewis Hamilton looked disheartened after failing to score points at the Hungarian Grand Prix. Hamilton failed to score points at one of his best tracks historically. He was stuck in waves of traffic due to his poor qualifying, which resulted in him qualifying 12th. His struggles are a drop in a bucket of lackluster results this season for the seven-time champion. Hamilton made the massive move to the most storied team on the Formula 1 grid this season, and following months of anticipation and hype, he hasn't lived up to the expectations. Lewis Hamilton of Great Britain and Scuderia Ferrari is interviewed during practice ahead of the F1 Grand Prix of Hungary at Hungaroring on August 01, 2025 in Budapest, Hungary. Lewis Hamilton of Great Britain and Scuderia Ferrari is interviewed during practice ahead of the F1 Grand Prix of Hungary at Hungaroring on August 01, 2025 in Budapest, Hungary. Photo byOn Saturday, after qualifying, Hamilton appeared devastated and even claimed that the team should change their driver. "It's just me every time. I am useless. Absolutely useless. The team has no problem. You can see the car is on pole [with Leclerc]. They probably need to change driver," Hamilton said. Then following the race, the British driver sounded dispondent and revealed additional information regarding his comments. "Not particularly, when you have a feeling, you have a feeling. There's a lot going on in the background that's not great, so...," Hamilton told Sky Sports. "I still love it. I still love racing." In Hungary, Hamilton started on the hard tire, lasting 40 laps on the compound before swapping onto the medium tire. He started in the same place he finished, marking what has been a frustrating weekend for the driver. Hamilton had an amazing drive during the Belgian Grand Prix, earning driver of the day after making up serious ground. He looked poised to keep the momentum going in Hungary. This makes his poor race weekend all the more painful for the champion and likely explains his absolute lack of confidence. Former Ferrari team boss Stefano Domenicali still thinks Hamilton can turn it around in the second half of the season. "First of all, Lewis is a jewel, he is an incredible athlete, so no matter if it is a difficult moment, he will react, and I'm pretty sure he will show the reason why he is here," Domenicali told Sky Sports F1. "He wants to achieve his eighth title, and he will triumph again. So, stay with Lewis and he will do a great race, and be very, very strong after the summer [break]." Hungarian Grand Prix Race Results Lando Norris (McLaren) Oscar Piastri (McLaren) George Russell (Mercedes) Charles Leclerc (Ferrari) Fernando Alonso (Aston Martin) Gabriel Bortoleto (Sauber) Lance Stroll (Aston Martin) Liam Lawson (Racing Bulls) Max Verstappen (Red Bull) Kimi Antonelli (Mercedes) Isack Hadjar (Racing Bulls) Lewis Hamilton (Ferrari) Nico Hulkenberg (Sauber) Carlos Sainz (Williams) Alex Albon (Williams) Esteban Ocon (Haas) Yuki Tsunoda (Racing Bulls) Franco Colapinto (Alpine) Pierre Gasly (Alpine) DNF: Ollie Bearman (Haas)
Yahoo
4 hours ago
- Yahoo
Ferrari boss confident 'frustrated' Hamilton will bounce back after Hungarian GP
Lewis Hamilton received support from his Ferrari team boss Fred Vasseur on Sunday just hours after the Briton cut a dejected figure following a lacklustre drive to 12th place in the Hungarian Grand Prix. While team-mate Charles Leclerc proved unable to convert Ferrari's first pole position of the season into victory due to unexplained mechanical problems during the race, seven-time champion Hamilton was battling to escape midfield and finished where he started. As on Saturday, when he was dumped out of Q2 and appeared miserable, claiming he was "completely useless" and saying the team should "bring in another driver", Hamilton seemed utterly deflated. To most observers, it appeared as if the pressures of living up to the hype of his spectacular marquee move from Mercedes, where he won six titles, and adjusting to the culture, car and expectations at Ferrari were overwhelming him. At 40, talk of imminent retirement circled around him. But Vasseur was swift to defend Hamilton, who has always been prone to impulsive heart-on-sleeve reactions. "I don't need to motivate him," said Vasseur. "Honestly, he's frustrated, but not demotivated. "He's demanding, but I think it's also why he's (a) seven-time world champion. I can perfectly understand this situation. "Sometimes, you are making comments on what the driver is saying (in) the car, but if you put the microphone on some other sportsmen, in football and so on, I'm not sure that it would be much better. "Sometimes, just after the race or just after qualifying, you are very disappointed and the first reaction is harsh. I can understand the frustration, but we are all frustrated." - 'He will be back' - Vasseur added Hamilton's weekend appeared worse than it really was because of the tight and competitive times that led him to miss out on reaching Q3 on Saturday. "For sure, when you are a seven-time world champion, your team-mate is on pole position and you are out in Q2, it's a tough situation," he said. "But overall, we can also have a deep look that he was in front of Charles in Q1 and with the first set that he was one-tenth off in Q2. We were not far away from having the two cars out in Q2. "I can understand the frustration from Lewis. That's normal and he will come back. He was stuck in a DRS train, but when he was alone, the pace was good. "I'm sure that he will be back and he will perform." Fourth-placed Leclerc backed his team-mate. "At the end, we are one team and as much as I want to finish in front of Lewis, I want both of us to be successful and for Ferrari to be successful, and obviously this weekend has been a tough one for Lewis," Leclerc said. "But I have no doubt that it's a one-off and I'm sure the second part of the season will be a lot more positive." Hamilton, sixth in the drivers' standings, but without a podium for Ferrari this year, said he was looking forward to a much-needed "break from work" during F1's August holiday before the Dutch Grand Prix on the final weekend of this month. str/iwd/nf
